logo
Share SHARE
FONT-SIZE Plus   Neg

Merck Reports New Data From 2 Pivotal Phase III Efficacy Trials For Suvorexant

Merck (MRK) announced new data from two pivotal Phase III efficacy trials for suvorexant, the investigational medicine company is developing for the treatment of insomnia.

In the studies, suvorexant significantly reduced the time it took patients to fall asleep and increased the time that patients stayed asleep as early as the first night and at the three-month time point compared to placebo. Merck noted that the investigational medicine met statistical significance for all primary endpoints except for one measurement at month 3 in one of the trials. These late-breaking data were presented today at SLEEP 2012, the 26th Annual Meeting of the Associated Professional Sleep Societies.

Darryle Schoepp, senior vice president and head of Neuroscience and Ophthalmology franchise, Merck Research Laboratories, stated, "Suvorexant approaches insomnia differently than other medicines because it helps patients to sleep by targeting and blocking orexins, which play a role in keeping people awake. We're excited about the Phase III results and the potential of suvorexant to become the first in a new class of medicines to help patients with insomnia."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
KFC has brought its "Finger Lickin' Good" tag line to life by creating KFC-flavored nail polishes. KFC Hong Kong has partnered with advertising agency Ogilvy & Mather to make "Original" and "Hot & Spicy" edible nail polishes. The flavors contain natural ingredients and are based on KFC's two popular... Telecom giant AT&T Inc. has awarded a contract to host its web and mobile portals to Synacor Inc., ending a major portion of its 15-year old deal with Yahoo! Inc. The move by AT&T deals a blow to Yahoo!'s already shrinking search and display ad business and comes at a time when the struggling Internet giant is weighing offers from potential bidders. Chinese e-commerce giant Alibaba Group Holding Limited on Thursday reported an 85 percent surge in profit for the fourth quarter from last year on strong revenue growth, mainly driven by the continued rapid growth of the company's China commerce retail business. Shares of the company are gaining almost 3 percent in pre-market activity.
comments powered by Disqus
Follow RTT